Rationale: Host inflammatory responses have been strongly associated with adverse outcomes in critically ill patients, but the biologic underpinnings of such heterogeneous responses have not been defined. Objectives: We examined whether respiratory tract microbiome profiles are associated with host inflammation and clinical outcomes of acute respiratory failure. Methods: We collected oral swabs, endotracheal aspirates (ETAs), and plasma samples from mechanically ventilated patients. We performed 16S ribosomal RNA gene sequencing to characterize upper and lower respiratory tract microbiota and classified patients into host-response subphenotypes on the basis of clinical variables and plasma biomarkers of innate immunity and inflammation. We derived diversity metrics and composition clusters with Dirichlet multinomial models and examined our data for associations with subphenotypes and clinical outcomes.Measurements and Main Results: Oral and ETA microbial communities from 301 mechanically ventilated subjects had substantial heterogeneity in α and β diversity. Dirichlet multinomial models revealed a cluster with low α diversity and enrichment for pathogens (e.g., high Staphylococcus or Pseudomonadaceae relative abundance) in 35% of ETA samples, associated with a hyperinflammatory subphenotype, worse 30-day survival, and longer time to liberation from mechanical ventilation (adjusted P < 0.05), compared with patients with higher α diversity and relative abundance of typical oral microbiota. Patients with evidence of dysbiosis (low α diversity and low relative abundance of "protective" oral-origin commensal bacteria) in both oral and ETA samples (17%, combined dysbiosis) had significantly worse 30-day survival and longer time to liberation from mechanical ventilation than patients without dysbiosis (55%; adjusted P < 0.05).Conclusions: Respiratory tract dysbiosis may represent an important, modifiable contributor to patient-level heterogeneity in systemic inflammatory responses and clinical outcomes.
Rationale: Host inflammatory responses have been strongly associated with adverse outcomes in critically ill patients, but the biologic underpinnings of such heterogeneous responses have not been defined. Objectives: We examined whether respiratory tract microbiome profiles are associated with host inflammation and clinical outcomes of acute respiratory failure. Methods: We collected oral swabs, endotracheal aspirates (ETAs), and plasma samples from mechanically ventilated patients. We performed 16S ribosomal RNA gene sequencing to characterize upper and lower respiratory tract microbiota and classified patients into host-response subphenotypes on the basis of clinical variables and plasma biomarkers of innate immunity and inflammation. We derived diversity metrics and composition clusters with Dirichlet multinomial models and examined our data for associations with subphenotypes and clinical outcomes.Measurements and Main Results: Oral and ETA microbial communities from 301 mechanically ventilated subjects had substantial heterogeneity in α and β diversity. Dirichlet multinomial models revealed a cluster with low α diversity and enrichment for pathogens (e.g., high Staphylococcus or Pseudomonadaceae relative abundance) in 35% of ETA samples, associated with a hyperinflammatory subphenotype, worse 30-day survival, and longer time to liberation from mechanical ventilation (adjusted P < 0.05), compared with patients with higher α diversity and relative abundance of typical oral microbiota. Patients with evidence of dysbiosis (low α diversity and low relative abundance of "protective" oral-origin commensal bacteria) in both oral and ETA samples (17%, combined dysbiosis) had significantly worse 30-day survival and longer time to liberation from mechanical ventilation than patients without dysbiosis (55%; adjusted P < 0.05).Conclusions: Respiratory tract dysbiosis may represent an important, modifiable contributor to patient-level heterogeneity in systemic inflammatory responses and clinical outcomes.
Authors: Katie R Famous; Kevin Delucchi; Lorraine B Ware; Kirsten N Kangelaris; Kathleen D Liu; B Taylor Thompson; Carolyn S Calfee Journal: Am J Respir Crit Care Med Date: 2017-02-01 Impact factor: 21.405
Authors: L D Bos; L R Schouten; L A van Vught; M A Wiewel; D S Y Ong; O Cremer; A Artigas; I Martin-Loeches; A J Hoogendijk; T van der Poll; J Horn; N Juffermans; C S Calfee; M J Schultz Journal: Thorax Date: 2017-04-27 Impact factor: 9.139
Authors: Daphnée Lamarche; Jennie Johnstone; Nicole Zytaruk; France Clarke; Lori Hand; Dessi Loukov; Jake C Szamosi; Laura Rossi; Louis P Schenck; Chris P Verschoor; Ellen McDonald; Maureen O Meade; John C Marshall; Dawn M E Bowdish; Tim Karachi; Diane Heels-Ansdell; Deborah J Cook; Michael G Surette Journal: Respir Res Date: 2018-12-07
Authors: Georgios D Kitsios; Adam Fitch; Dimitris V Manatakis; Sarah F Rapport; Kelvin Li; Shulin Qin; Joseph Huwe; Yingze Zhang; Yohei Doi; John Evankovich; William Bain; Janet S Lee; Barbara Methé; Panayiotis V Benos; Alison Morris; Bryan J McVerry Journal: Front Microbiol Date: 2018-07-10 Impact factor: 5.640
Authors: Imran Sulaiman; Matthew Chung; Luis Angel; Jun-Chieh J Tsay; Benjamin G Wu; Stephen T Yeung; Kelsey Krolikowski; Yonghua Li; Ralf Duerr; Rosemary Schluger; Sara A Thannickal; Akiko Koide; Samaan Rafeq; Clea Barnett; Radu Postelnicu; Chang Wang; Stephanie Banakis; Lizzette Pérez-Pérez; Guomiao Shen; George Jour; Peter Meyn; Joseph Carpenito; Xiuxiu Liu; Kun Ji; Destiny Collazo; Anthony Labarbiera; Nancy Amoroso; Shari Brosnahan; Vikramjit Mukherjee; David Kaufman; Jan Bakker; Anthony Lubinsky; Deepak Pradhan; Daniel H Sterman; Michael Weiden; Adriana Heguy; Laura Evans; Timothy M Uyeki; Jose C Clemente; Emmie de Wit; Ann Marie Schmidt; Bo Shopsin; Ludovic Desvignes; Chan Wang; Huilin Li; Bin Zhang; Christian V Forst; Shohei Koide; Kenneth A Stapleford; Kamal M Khanna; Elodie Ghedin; Leopoldo N Segal Journal: Nat Microbiol Date: 2021-08-31 Impact factor: 17.745
Authors: Robinder G Khemani; Jessica T Lee; David Wu; Edward J Schenck; Margaret M Hayes; Patricia A Kritek; Gökhan M Mutlu; Hayley B Gershengorn; Rémi Coudroy Journal: Am J Respir Crit Care Med Date: 2021-05-01 Impact factor: 21.405
Authors: Eleanor Valenzi; Haopu Yang; John C Sembrat; Libing Yang; Spencer Winters; Rachel Nettles; Daniel J Kass; Shulin Qin; Xiaohong Wang; Michael M Myerburg; Barbara Methé; Adam Fitch; Jonathan K Alder; Panayiotis V Benos; Bryan J McVerry; Mauricio Rojas; Alison Morris; Georgios D Kitsios Journal: Thorax Date: 2020-12-02 Impact factor: 9.139
Authors: Nanon F L Heijnen; Laura A Hagens; Marry R Smit; Marcus J Schultz; Tom van der Poll; Ronny M Schnabel; Iwan C C van der Horst; Robert P Dickson; Dennis C J J Bergmans; Lieuwe D J Bos Journal: Physiol Rep Date: 2021-02
Authors: Emma M de Koff; Wing Ho Man; Marlies A van Houten; Nicolaas J G Jansen; Kayleigh Arp; Raiza Hasrat; Elisabeth A M Sanders; Debby Bogaert Journal: Eur Respir J Date: 2021-04-01 Impact factor: 16.671
Authors: Georgios D Kitsios; Daniel Kotok; Haopu Yang; Malcolm A Finkelman; Yonglong Zhang; Noel Britton; Xiaoyun Li; Marina S Levochkina; Amy K Wagner; Caitlin Schaefer; John J Villandre; Rui Guo; John W Evankovich; William Bain; Faraaz Shah; Yingze Zhang; Barbara A Methé; Panayiotis V Benos; Bryan J McVerry; Alison Morris Journal: JCI Insight Date: 2021-07-22
Authors: William Bain; Haopu Yang; Faraaz Ali Shah; Tomeka Suber; Callie Drohan; Nameer Al-Yousif; Rebecca S DeSensi; Nicole Bensen; Caitlin Schaefer; Brian R Rosborough; Ashwin Somasundaram; Creg J Workman; Caleb Lampenfeld; Anthony R Cillo; Carly Cardello; Feng Shan; Tullia C Bruno; Dario A A Vignali; Prabir Ray; Anuradha Ray; Yingze Zhang; Janet S Lee; Barbara Methé; Bryan J McVerry; Alison Morris; Georgios D Kitsios Journal: Ann Am Thorac Soc Date: 2021-07